Page last updated: 2024-10-27

gabexate and Adenoma, Basal Cell

gabexate has been researched along with Adenoma, Basal Cell in 2 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"He was diagnosed as metastatic bone cancer with disseminated intravascular coagulation (DIC)."1.28Disseminated carcinomatosis of bone marrow from submucosal carcinoma in adenoma of the rectum. ( Andachi, H; Shimizu, H; Yokoo, S; Yoshioka, K, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshioka, K1
Shimizu, H1
Yokoo, S1
Andachi, H1
Silverman, JA1
Kuhlmann, ET1
Zurlo, J1
Yager, JD1
Longnecker, DS1

Other Studies

2 other studies available for gabexate and Adenoma, Basal Cell

ArticleYear
Disseminated carcinomatosis of bone marrow from submucosal carcinoma in adenoma of the rectum.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:8

    Topics: Adenoma; Anemia, Hemolytic; Antithrombin III; Bone Neoplasms; Carcinoma; Disseminated Intravascular

1992
Expression of c-myc, c-raf-1, and c-Ki-ras in azaserine-induced pancreatic carcinomas and growing pancreas in rats.
    Molecular carcinogenesis, 1990, Volume: 3, Issue:6

    Topics: Adenoma; Animals; Azaserine; Blotting, Northern; Carcinoma; Cell Cycle; Esters; Gabexate; Gene Expre

1990